• 1
    IARC. Handbooks of cancer prevention. I. Non-steroidal anti-inflammatory drugs. Lyon: IARC, 1997.
  • 2
    Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 2002; 94: 25266.
  • 3
    Beauparlant P, Papp K, Haraoui B. The incidence of cancer associated with the treatment of rheumatoid arthritis. Semin Arthritis Rheum 1999; 29: 14858.
  • 4
    Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, Hoover R, Fraumeni JF Jr. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993; 85: 30711.
  • 5
    Cartwright RA, McKinney PA, O'Brien C, Richards DG, Roberts B, Lauder I, Darwin M, Bernard SM, Bird CC. Non-Hodgkin's lymphoma: a case-control epidemiologic study in Yorkshire. Leuk Res 1988; 13: 46572.
  • 6
    Schreinemachers DM, Everson RB. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 1994; 5: 13846.
  • 7
    Bernstein L, Ross RK. Prior medication use and health history as risk factors for non-Hodgkin's lymphoma: preliminary results from a case-control study in Los Angeles County. Cancer Res 1992; 52: 5510s15s.
  • 8
    Holly EA, Lele C, Bracci PM, McGrath MS. Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol 1999; 150: 37589.
  • 9
    Cerhan JR, Wallace RB, Folsom AR, Potter JD, Sellers TA, Zheng W, Lutz CT. Medical history risk factors for non-Hodgkin's lymphoma in older women. J Natl Cancer Inst 1997; 89: 3148.
  • 10
    Cerhan JR, Wallace RB, Dick F, Kemp J, Parker AS, Zheng W, Sellers TA, Folsom AR. Blood transfusion and risk of non-Hodgkin lymphoma subtypes and chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev 2001; 10: 3618.
  • 11
    Folsom AR, Kaye SA, Prineas RJ, Potter JD, Gapstur SM, Wallace RB. Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol 1990; 131: 794803.
  • 12
    Bisgard KM, Folsom AR, Hong CP, Sellers TA. Mortality and cancer rates in nonrespondents to a prospective cohort study of older women: 5-year follow-up. Am J Epidemiol 1994; 139: 9901000.
  • 13
    Ries LG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK. SEER cancer statistics review, 1973–1998. Bethesda, MD: National Cancer Institute, 2001.
  • 14
    Percy C, Van Holten V, Muir C. International classification of diseases for oncology, 2nd ed. Geneva: WHO, 1990.
  • 15
    Percy C, O'Conor G, Ries L, Jaffe E. Non-Hodgkin's lymphoma: application of the international classification of diseases for oncology (ICD-O) to the working formulation. Cancer 1984; 54: 14358.
  • 16
    Cox DR. Regression models and life tables (with discussion). J R Stat Soc B 1972; 34: 187220.
  • 17
    Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 1997; 145: 7280.
  • 18
    Folsom AR, Zhang S, Sellers TA, Zheng W, Kushi LH, Cerhan JR. Cancer incidence among women living on farms: findings from the Iowa Women's Health Study. J Occup Environ Med 1996; 38: 11716.
  • 19
    Chiu BC, Cerhan JR, Gapstur SM, Sellers TA, Zheng W, Lutz CT, Wallace RB, Potter JD. Alcohol consumption and non-Hodgkin lymphoma in a cohort of older women. Br J Cancer 1999; 80: 147682.
  • 20
    Parker AS, Cerhan JR, Dick F, Kemp J, Habermann TM, Wallace RB, Sellers TA, Folsom AR. Smoking and risk of non-Hodgkin's lymphoma subtypes in a cohort of older Iowa women. Leuk Lymphoma 2000; 37: 3419.
  • 21
    Chiu BC, Cerhan JR, Folsom AR, Sellers TA, Kushi LH, Wallace RB, Zheng W, Potter JD. Diet and risk of non-Hodgkin lymphoma in older women. JAMA 1996; 275: 131521.
  • 22
    Cerhan JR, Vachon CM, Habermann TM, Ansell SM, Witzig TE, Kurtin PJ, Janney CA, Zheng W, Potter JD, Sellers TA, Folsom AR. Hormone replacement therapy and risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev 2002; 11: 146671.
  • 23
    Anderson KE, Johnson TW, Lazovich D, Folsom AR. Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of pancreatic cancer. J Natl Cancer Inst 2002; 94: 116871.
  • 24
    Johnson TW, Anderson KE, Lazovich D, Folsom AR. Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of post-menopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2002; 11: 158691.
  • 25
    Herrinton LJ. Epidemiology of the revised European-American lymphoma classification subtypes. Epidemiol Rev 1998; 20: 187203.
  • 26
    Rosenberg L. Nonsteroidal anti-inflammatory drugs and cancer. Prev Med 1995; 24: 1079.
  • 27
    Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW Jr. Aspirin use and risk of fatal cancer. Cancer Res 1993; 53: 13227.
  • 28
    Isomaki HA, Hakulinen T, Joutsenlahti U. Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis 1978; 31: 6916.
  • 29
    Mellemkjaer L, Linet MS, Gridley G, Frisch M, Moller H, Olsen JH. Rheumatoid arthritis and cancer risk. Eur J Cancer 1996; 32A: 17537.
  • 30
    Tennis P, Andrews E, Bombardier C, Wang Y, Strand L, West R, Tilson H, Doi P. Record linkage to conduct an epidemiologic study on the association of rheumatoid arthritis and lymphoma in the Province of Saskatchewan, Canada. J Clin Epidemiol 1993; 46: 68595.
  • 31
    Balint G, Gergely P Jr. Clinical immunotoxicity of antirheumatic drugs. Inflamm Res 1996; 45: S915.
  • 32
    Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood 2002; 99: 390915.
  • 33
    Baecklund E, Ekbom A, Sparen P, Feltelius N, Klareskog L. Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study. British Medical Journal 1998; 317: 1801.
  • 34
    Kamel OW, Holly EA, van de Rijn M, Lele C, Sah A. A population based, case control study of non-Hodgkin's lymphoma in patients with rheumatoid arthritis. J Rheumatol 1999; 26: 167680.
  • 35
    Tilley SL, Coffman TM, Koller BH. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 2001; 108: 1523.
  • 36
    Cianferoni A, Schroeder JT, Kim J, Schmidt JW, Lichtenstein LM, Georas SN, Casolaro V. Selective inhibition of interleukin-4 gene expression in human T cells by aspirin. Blood 2001; 97: 17429.
  • 37
    Kopp E, Ghosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science 1994; 265: 9569.
  • 38
    Li Q, Verma IM. NF-κB regulation in the immune system. Nat Rev Immunol 2002; 2: 72534.